DMD Large equally mixed donor pool

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on September 29, 2006; DOI: 10.1124/dmd.106.012062


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.106.012062v1
35/1/43    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Newman, D.
Right arrow Articles by Pushkin, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Newman, D.
Right arrow Articles by Pushkin, A.


Received for publication July 19, 2006.
Revised September 22, 2006.
Accepted for publication September 25, 2006.

Specificity of Aminoacylase III Mediated Deacetylation of Mercapturic Acids

Debra Newman 1, Natalia Abuladze 1, Karoline Scholz 2, Wolfgang Dekant 2, Vladimir Tsuprun 3, Sergey Ryazantsev 1, Galyna Bondar 1, Pakan Sassani 1, Ira Kurtz 1, Alexander Pushkin 1*

1 UCLA 2 University of Wurzburg 3 University of MInnesota

* Address correspondence to: E-mail: apushkin{at}mednet.ucla.edu

Abstract

Trichloroethylene (TCE) and other halogenated alkenes are known environmental contaminants with cytotoxic and nephrotoxic effects, and potential carcinogens. Their metabolism via the mercapturate metabolic pathway was shown to lead to their detoxification. The final products of this pathway, mercapturic acids or N-acetyl-L-cysteine S-conjugates are secreted into the lumen in the renal proximal tubule. The proximal tubule may also deacetylate mercapturic acids, and the resulting cysteine S-conjugates are transformed by cysteine S-conjugate {beta}-lyases to nephrotoxic reactive thiols. The specificity and rate of mercapturic acid deacetylation may determine the toxicity of certain mercapturic acids, however the exact enzymologic processes involved are not known in detail. In the present study we characterized the kinetics of the recently cloned mouse aminoacylase III (AAIII) towards a wide spectrum of halogenated mercapturic acids and N-acetylated amino acids. In general, the Vmax value of AAIII was significantly larger with chlorinated and brominated mercapturic acids whereas fluorination significantly decreased it. The enzyme deacetylated mercapturic acids derived from the TCE metabolism including N-acetyl-S-(1,2-dichlorovinyl)-L-cysteine (NA-1,2-DCVC) and N-acetyl-S-(2,2-dichlorovinyl)-L-cysteine (NA-2,2-DCVC). Both mercapturic acids induced cytotoxicity in mouse proximal tubule mPCT cells expressing AAIII, which was decreased by an inhibitor of {beta}-lyase, aminooxyacetate. The toxic effect of NA-2,2-DCVC was smaller than NA-1,2-DCVC indicating that factors other than the intracellular activity of AAIII mediate the cytotoxicity of these mercapturic acids. Our results indicate that in proximal tubule cells AAIII plays an important role in deacetylating several halogenated mercapturic acids and this process may be involved in their cyto- and nephrotoxicity.


Key words: bioactivation, enzyme kinetics, glutathione-dependent toxicity, renal toxicity





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.